Sanofi to explore acquisition of cancer drugmaker Mirati- Bloomberg News
(Reuters) – Paris-based drugmaker Sanofi is exploring a potential acquisition of cancer drugmaker Mirati Therapeutics, Bloomberg News reported on Thursday citing people familiar with the matter. Deliberations are ongoing and there is…
Roche buys back shares as family group reduces voting stake in drugmaker
ZURICH (Reuters) – Roche has bought 540,000 of its own shares, the company said on Friday, as a member of its controlling family group scaled back their investment in voting shares at…
French drugmaker Sanofi expects positive boost from currency markets in Q3
PARIS (Reuters) -French drugmaker Sanofi said it expected a positive boost to its third-quarter business results from movements on the currency markets, helped by the strength of the U.S. dollar since Sanofi…
Senate Finance Committee looks at Amgen taxes, widening drugmaker probe
By Michael Erman NEW YORK – The U.S. Senate Finance Committee is widening its investigation into the tax practices of U.S. drugmakers to include Amgen Inc, according to a letter sent on…
Drugmaker Gilead to help fund monkeypox education for LGBTQ+ groups
By Nancy Lapid (Reuters) – Drugmaker Gilead Sciences plans to announce on Tuesday that it will provide up to $5 million in grants to help a coalition of LGBTQ+ and human rights…
Amarin to slash jobs as generic rivals dull U.S. prospects of heart drug
(Reuters) -Amarin Corp Plc said on Monday it would cut its workforce by 40%, as the drugmaker’s fish-oil derived heart drug faces stiff competition from generic rivals in the United States. About…
Drugmaker Teva may pay as much as $3.6 billion in U.S. opioid settlement
By Steven Scheer JERUSALEM -Teva Pharmaceutical Industries said on Wednesday it was bracing to pay as much as $3.6 billion in cash and medicine to settle thousands of lawsuits alleging it and…
Drugmaker Galapagos names former J&J exec Paul Stoffels as CEO
– Belgian drugmaker Galapagos NV on Wednesday named former Johnson & Johnson senior executive Paul Stoffels as its chief executive officer, effective April 1. Stoffels was the chief scientific officer of Johnson…
Drugmaker Teva fueled opioid addiction in New York, jury finds
(This Dec. 30 story refiles to add dropped words “members of” in last paragraph) By Brendan Pierson NEW YORK – Teva Pharmaceutical Industries Ltd fueled opioid addiction in New York state, a…
Breaking News
